[Skip navigation] FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule

Tentative Approvals - September 2005

  ANDA Number Generic Drug Name Applicant Tentative Approval Date
1 77-268 ZIDOVUDINE ORAL SOLUTION, USP 50 MG/5 ML   AUROBINDO PHARMA LIMITED 9/7/2005 
2 77-351 FAMOTIDINE TABLETS USP, 20 MG (OTC)   PERRIGO R&D COMPANY 9/9/2005 
3 77-100 DIVALPROEX SODIUM DELAYED-RELEASE TABLETS USP, 125 MG, 250 MG, AND 500 MG   ZYDUS PHARMACEUTICALS USA, INC. 9/9/2005 
4 77-143 DIVALPROEX SODIUM EXTENDED-RELEASE TABLETS, 250 MG   RANBAXY LABORATORIES LIMITED 9/12/2005 
5 77-261 GABAPENTIN CAPSULES, 100 MG, 300 MG, AND 400 MG   TARO PHARMACEUTICALS USA, INC. 9/13/2005 
6 77-018 METRONIDAZOLE TOPICAL GEL USP, 0.75%   ALTANA INC. 9/13/2005 
7 76-953 TOLTERODINE TARTRATE TABLETS, 1 MG AND 2 MG   RANBAXY LABORATORIES LIMITED 9/15/2005 
8 77-053 RIBAVIRIN TABLETS, 200 MG   TEVA PHARMACEUTICALS USA 9/15/2005 
9 77-206 SERTRALINE HYDROCHLORIDE TABLETS, 25 MG (BASE), 50 MG (BASE), AND 100 MG (BASE)   AUROBINDO PHARMA LIMITED 9/16/2005 
10 77-138 CIPROFLOXACIN AND DEXTROSE (5%) INJECTION USP, 2 MG/ML; 100 ML AND 200 ML PLASTIC CONTAINERS   SICOR PHARMACEUTICALS, INC. 9/21/2005 
11 77-274 GLIMEPIRIDE TABLETS, 1 MG, 2 MG, AND 4 MG   COREPHARMA, LLC 9/21/2005 
12 77-094 RIBAVIRIN TABLETS, 200 MG   ZYDUS PHARMACEUTICALS USA, INC. 9/30/2005 

Back to Top     Back to Approvals

Date created: October 12, 2005

horizonal rule